Treatment of COVID-19 with COVID-19-human immunoglobulin: A case report

VernacularTitle:静脉滴注 COVID-19 人免疫球蛋白治疗 COVID-19 一例
Author: Yi MAO ¹ ; He YU ² ; Zongan LIANG ³ ; Jiafu WEI ⁴ ; Guihui WU ² ; Haixia LUO ¹
Author Information

1. Emergency Section 2 of Public Health Clinical Center of Chengdu, Chengdu, 610061, P.R.China
2. Department of Tuberculosis of Public Health Clinical Center of Chengdu, Chengdu, 610061, P.R.China
3. Respiratory Department of West China Hospital, Sichuan University, Chengdu, 610041, P.R.China
4. Department of Cardiology of West China Hospital, Sichuan University, Chengdu, 610041, P.R.China
Publication Type:Journal Article
Keywords: Coronavirus disease 2019 (COVID-19); COVID-19-human immunoglobulin; case report
From: Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2021;28(11):1388-1392
CountryChina
Language:Chinese
Abstract: At present, there has been no report in China that novel coronavirus specific immune globulin has been used to treat coronavirus disease 2019 (COVID-19). Recently, we had successfully treated one COVID-19 patient with intravenous injection of human immunoglobulin (COVID-19-IVIG). The female patient, aged 57 years, had clinical diagnosis: (1) COVID-19, common type; (2) postoperative colon cancer; (3) leukopenia; (4) low cellular immunity. 75 mL COVID-19 human immunoglobulin (Sinoptic Wuhan Blood Products Co., Ltd.) was intravenously injected twice. The patient was hospitalized for 49 days and had a good prognosis.